Continue to Site

Drug Discovery and Development

Russia’s Sputnik-V vaccine has not yet received EU and WHO backing

By |

Sputnik V

Sputnik V in vials. Image from Mos.ru via Wikipedia.

The World Health Organization spokesperson Fadéla Chaib acknowledged undisclosed issues had delayed its emergency use authorization of Russia’s Sputnik V COVID-19 vaccine.

Chaib added that the WHO was working through the issues while Russian Health Minister Mikhail Murashko recently said Russian officials were completing the final paperwork needed for the filing.

Meanwhile, European Union officials have accused Russian officials of delaying inspections required for E.U. authorization of the vaccine.

Russian officials returned the criticism, blaming the European Medicines Agency for delaying authorization of the Sputnik V vaccine.

A recent press release from the Russian News Agency said it had filed paperwork related to mutual recognition of COVID vaccination certificates. The country is also preparing for a visit by EMA officials as part of the certification process for the Sputnik V vaccine.

To date, Sputnik V has found use in more than 70 countries.

Filed Under: Infectious Disease
Tagged With: , , , ,
 

About The Author

Brian Buntz

As the pharma and biotech editor at WTWH Media, Brian has almost two decades of experience in B2B media, with a focus on healthcare and technology. While he has long maintained a keen interest in AI, more recently Brian has made making data analysis a central focus, and is exploring tools ranging from NLP and clustering to predictive analytics.

Throughout his 18-year tenure, Brian has covered an array of life science topics, including clinical trials, medical devices, and drug discovery and development. Prior to WTWH, he held the title of content director at Informa, where he focused on topics such as connected devices, cybersecurity, AI and Industry 4.0. A dedicated decade at UBM saw Brian providing in-depth coverage of the medical device sector. Engage with Brian on LinkedIn or drop him an email at bbuntz@wtwhmedia.com.

Tell Us What You Think!

Related Articles Read More >

Search Drug Discovery & Development